Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

104 results
Display

Recent Advances in Palliative Chemotherapy for Unresectable Pancreatic Cancer

Ryu JK

Pancreatic adenocarcinoma is one of the fatalist malignancies. A large proportion of patients are diagnosed with unresectable stage pancreatic cancer at the time of presentation. Gemcitabine is a standard chemotherapeutic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antiviral Therapy in Hepatitis B Carriers Undergoing Immunosuppressive Treatment or Cytotoxic Chemotherapy

Yoon JH

  • KMID: 760574
  • Korean J Hepatol.
  • 2005 Mar;11(1):17-20.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnosis and therapy of multiple myeloma

Palumbo A, Cerrato C

Many advances in the treatment of multiple myeloma have been made due to the use of transplantation and the introduction of novel agents including thalidomide, lenalidomide, and bortezomib. The first...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives

Mabuchi S, Sugiyama T, Kimura T

Clear cell carcinoma (CCC) of the ovary is known to show poorer sensitivity to chemotherapeutic agents and to be associated with a worse prognosis than the more common serous adenocarcinoma...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gastric Metastasis from Breast Cancer

Yoon SY, Shim KN

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rare Frameshift Mutation Cys475Tyrfs*11 in the BCR/ABL Kinase Domain Contributes to Imatinib Mesylate Resistance in 2 Korean Patients with Chronic Myelogenous Leukemia

Park SH, Chi HS, Kwon MR, Cho YU, Jang S, Park CJ

  • KMID: 2434491
  • Ann Lab Med.
  • 2012 Nov;32(6):452-454.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Discrepant Results for BRAF V600E Mutation Among Different Specimens in a Case of Hairy Cell Leukemia

Moon HW, Hur M, Han SH, Yun YM, Kim SY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case with Coexistence of Major and Minor BCR/ABL Fusion Transcript at Lymphoblastic Crisis of Chronic Myelogenous Leukemia in Patients with Major BCR/ABL Positivity during Chronic Phase

Park SH, Chi HS, Cho YU, Jang S, Park CJ, Im HJ

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Rare Case of Chronic Myelogenous Leukemia and Plasma Cell Myeloma in the Same Patient

Ahn S, Park JS, Han JH, Cho SR

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Persistent suboptimal molecular response in a patient with chronic myelogenous leukemia and Klinefelter syndrome

Chakraborty R, Mukkamalla SKR, Singam K, Calderon N

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Two Cases of Acute Lymphoblastic Leukemia with an e1a3 BCR-ABL1 Fusion Transcript

Shin SY, Cho JH, Kim HJ, Jang JH, Lee ST, Kim SH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Two Lung Masses with Different Responses to Pemetrexed

Park KY, Jung JW, Nam SB, Lee HJ, Kim HS, Choi YH, Lee JC

We described here a patient who had two lung masses. Although the two masses had the same histology and a similar good response to initial chemotherapy with gemcitabine and carboplatin,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Second Line Chemotherapy for Pancreatic Cancer

Park JY

Pancreatic cancer is a very lethal cancer. It is the 5th most common cause for cancer related mortality in Korea. Most of patients have unresectable pancreatic cancer, and systemic chemotherapy...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Safety of Megestrol Acetate in Palliating Anorexia-Cachexia Syndrome in Patients with Castration-Resistant Prostate Cancer

Hong S, Jeong IG, You D, Lee JL, Hong JH, Ahn H, Kim CS

There are concerns whether megestrol acetate (MA) stimulates the growth of prostate cancer in castration-resistant prostate cancer (CRPC). We evaluated the effect of cumulative doses of MA on the disease-specific...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Chemotherapy for Colorectal Cancer

Hong YS, Kim TW

Recent advances in chemotherapy lead to improved survival outcomes in patients with colorectal cancer. The 5-fluorouracil (5-FU) is still one of the important chemotherapeutic agents since 1950s, but the introduction...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Improving survival after endometrial cancer: the big picture

Kwon JS

To improve survival in women with endometrial cancer, we need to look at the "big picture" beyond initial treatment. Although the majority of women will be diagnosed with early stage...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of Hepatocellular Carcinoma: Current Status and Future Directions

Au JS, Frenette C

Hepatocellular carcinoma (HCC) is the second most common cause of cancer death worldwide. This cancer commonly arises against a background of chronic liver disease. As a result, a patient with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer

Zhu X, Lang J

Programmed death-1 (PD-1) and its ligand are part of the immune checkpoint pathway that down-regulates effector T cells in immune response, thereby causing immune suppression. The PD-1/programmed death-ligand 1 (PD-L1)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current Status of Molecular Targeted Therapies in Hepatocellular Carcinoma

Suh SJ, Yim HJ

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death in Korea. Curative treatment is only possible when the disease is diagnosed at the early stage. The prognosis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of petroleum ether extract of Panax ginseng roots on proliferation and cell cycle progression of human renal cell carcinoma cells

Sohn J, Lee CH, Chung DJ, Park SH, Kim IS, Hwang WI

  • KMID: 754987
  • Exp Mol Med.
  • 1998 Mar;30(1):47-51.
Panax ginseng roots have long been used as a medicinal herb in oriental countries. We have investigated anti-proliferative effects of lipid soluble Panax ginseng components on human renal cancer cell lines. Petroleum...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr